Bone Growth Stimulator Market
Bone Growth Stimulator Market by Product (Bone Growth Stimulation Devices, Platelet-Rich Plasma Bone Growth Stimulators, Bone Morphogenetic Protein Stimulators), by End User, by Application & Regional Analysis till 2032
Analysis of Bone Growth Stimulator market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Bone Growth Stimulator Market Outlook (2022 to 2032)
The global bone growth stimulator market was valued at US$ 1.89 Billion in 2021. By 2022, the market is expected to touch a valuation of US$ 1.99 Billion, exhibiting a Y-o-Y increase of 5.3%. During the forecast period of 2022 to 2032, the bone growth stimulator market is anticipated to display a CAGR of 5.07% while securing a value worth US$ 3.1 Billion. The expansion of the market can be attributed to the increasing incidence of arthritis across the globe.
| Report Attributes | Details |
|---|---|
| Anticipated Base Year Value (2021) | US$ 1.89 Billion |
| Expected Market Value (2022) | US$ 1.99 Billion |
| Projected Forecast Value (2032) | US$ 3.1 Billion |
| Global Growth Rate (2022-2032) | 5.07% |
| Major Bone Growth Stimulator Provider | Ossatec Benelux B.V.; Elizur Corporation; Johnson & Johnson; Arthrex Inc.; DJO Global Inc.; Stryker Corporation; Bioventus Inc.; Zimmer Biomet Holdings Inc.; Medtronic plc.; Orthofix International N.V. |
Bone growth stimulator devices are medical equipment that boosts the fracture healing process in cases of delay or failure. They pump the regular speed of healing by giving electric shocks to patients. Some bone growth stimulators available in the market comprise bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma.
There are three types of bone growth stimulation equipment, which include pulsed electromagnetic field devices, combines magnetic field devices, and capacitive coupling devices.
2017 to 2021 Revenue Analysis of Bone Growth Stimulator Market Vs Future Outlook 2022 to 2032
During the forecast period of 2017 to 2021, the global bone growth stimulator market is anticipated to display a CAGR of 4.8%. The growth of the market can be attributed to the rising geriatric population, and increasing cases of fractures and accidents. As per WHO, by 2030, 1 in 6 people in the world will be aged 60 years or over. Other factors supporting the market growth include the growing demand for minimally invasive & non-invasive surgical treatments.
In addition, growing approvals by regulatory authorities are anticipated to have boosted the market growth during the aforementioned time. For instance, in February 2020, US FDA approved STIMonTrack. The STIMonTrack technology is designed to work with Orthofix bone growth therapy devices and assist patients to adhere to their prescriptions and boost clinical outcomes. Such factors are anticipated to have made significant contributions to developing the market during the forecast period.
From 2022 to 2032, the global bone growth stimulator market is projected to display a CAGR of 5.07%. The development of the market can be attributed to the changing lifestyle of people. Increasing obesity, smoking, and diabetes, among others, are expected to support the industry’s growth during the forecast period. In addition, increasing agreements among players is anticipated to benefit the market during the forecast period.
For instance, in 2021, Orthofix inked an agreement to commercialize the innovative portfolio of IGEA’s bone, soft tissue stimulation, and cartilage products in the US and Canada. Attributed to the aforementioned factors, the industry is likely to flourish during the forecast period.
Major Factors Driving the Global Bone Growth Stimulator Market
Increasing Preference for Non-Invasive Bone Growth to Drive the Market
The growing preference and adoption of non-invasive bone growth stimulators are expected to play a major role in driving the market during the forecast period. Non-invasive stimulators use ultrasonic, magnetic, or electrical signals to stimulate osteogenesis in conjunction with a spinal fusion of fracture fixation.
The equipment is applied over the location of a fracture for a period of time during the treatment procedure. Players marketing such equipment are Orthofix, Zimmer Biomet, and DJO, among others.
In September 2017, Orthofix announced the approvals of the European CE Mark and the U.S FDA for its next-generation SpinalStim and CervicalStim bone growth stimulator. Such equipment help to enhance the body’s natural healing process, providing patients with a non-invasive and safe treatment for promoting postoperative spinal fusion.
Further, the growing occurrence of bone diseases across the globe is projected to drive the market during the forecast period. Increasing incidences of osteoporosis are projected to be the leading cause of fractures across the globe, thus, benefitting the industry in the forecast period.
Moreover, the rising diagnosis of such conditions along with rapid technological development for better treatment will further propel the market growth in the coming time. Besides, the rising number of oral and maxillofacial surgeries across the globe will strengthen the industry’s growth in the forecast period.
Increasing R&D Activities along with Rising Number of Product Launches to Widen the Market Size
Growing efforts from various manufacturers to develop novel and advanced products in the market are anticipated to benefit the market growth during the forecast period. Along with this, the rising number of product launches owing to increased approval from the regulatory authority bodies is likely to augment the market size.
For instance, in May 2022, Orthofix Medical Inc., a global medical device company with a spine and orthopedics focus, announced the U.S. Food and Drug Administration (FDA) pre-market approval for the AccelStim™ bone healing therapy Class III device.
The AccelStim device provides a safe and effective nonsurgical treatment for indicated fresh fractures and for fractures that have not healed (nonunions). Such factors are expected to benefit the market during the forecast period.
Factors Hampering the Bone Growth Stimulator Market
Limited Medical Reimbursement for Bone Stimulation Products
Medical reimbursement is among the major factors that is expected to negatively impact the market during the forecast period. Various healthcare insurance providers offer growth stimulation products under specific conditions. For example, in the U.S, bone growth stimulation devices are covered under insurance if target bones are separated by less than 1 centimeter or are non-infected.
Another factor hampering the market is the rising product launched that have surged the number of product recalls across the globe. In November 2018, Zimmer Biomet recalled 1,300 bone growth and spinal fusion stimulators. Such factors are expected to hamper the market growth during the forecast period.
Comparative View of Bone Growth Stimulator Market
Bone Growth Stimulator Market :
| Attributes | Bone Growth Stimulator Market |
|---|---|
| CAGR (2022 to 2032) | 5.07% |
| Market Value (2032) | US$ 3.1 Billion |
| Growth Factor | The growing occurrence of bone diseases across the globe and rising incidences of osteoporosis are projected to be the leading cause of fractures across the globe, benefitting the industry in the forecast period. |
| Opportunity | Growing efforts from various manufacturers to develop novel and advanced products in the market are anticipated to benefit the market growth during the forecast period. Along with this, the rising number of product launches owing to increased approval from the regulatory authority bodies is likely to augment the market size. |
Patient Lateral Transfer Devices Market :
| Attributes | Patient Lateral Transfer Devices Market |
|---|---|
| CAGR (2022 to 2032) | 6.72% |
| Market Value (2032) | US$ 500 Million |
| Growth Factor | The application of patient transfer accessories is being emphasized by healthcare experts to prevent back injuries since such devices help smooth patient transfer by enhancing postures while moving partially or completely dependent patients. |
| Opportunity | Implementation of government laws to lessen the duration and cost of home healthcare services in the market is expected to offer remunerative opportunities to the market during the forecast period. |
Bone Grafts and Substitutes Market :
| Attributes | Bone Grafts and Substitutes Market |
|---|---|
| CAGR (2022 to 2032) | 5.45% |
| Market Value (2032) | US$ 5.2 Billion |
| Growth Factor | Increasing demand for synthetic and xenografts and growing usage of bone graft substitutes in regenerative medicines are expected to benefit the global bone growth stimulator market during the forecast period. |
| Opportunity | Growing orthopedic surgeries and R&D initiatives are expected to offer significant growth opportunities to the market in the forecast period. Researchers across the globe are taking various initiatives to find new ways to use bone grafts in regenerative medicines, which can widen the market size in the forecast tenure. |
Segmentation Analysis
What is the Contribution of Hospitals & Clinic Segment in Developing the Bone Growth Stimulator Market?
High Number of Patient Visits to Develop the Segment during the Forecast Period
As per the study, the hospitals and clinic segment is anticipated to dominate the market during the forecast period. The dominance can be attributed to the increasing number of patient visits and many orthopedic procedures being conducted in hospitals.
In 2018, in the American Hospital Association, the total number of hospitals in the U.S amounted to 6,146, with the number of staffed hospital beds counting at 924,107. Such factors are expected to benefit the market during the forecast period.
What is the Role of the Spinal Fusion Segment in Strengthening the Bone Growth Stimulator Market?
Large Number of Patient Pools Undergoing Spinal Fusion Surgeries to Favor the Segment Growth
The spinal fusion segment is expected to dominate the market during the forecast period. The development of the segment can be attributed to the increasing number of patient pools undergoing spinal fusion surgeries across the globe. Also, the high price of the procedure along with the rising volume of surgeries are the salient factors supporting the segmental growth during the forecast period.
Regional Analysis
How is the Developed Healthcare Sector Driving the Bone Growth Stimulator Market in North America?
According to the analysis, North America is expected to dominate the market during the forecast period. The domination of the region can be attributed to the highly developed healthcare infrastructure and reimbursement system. The growing incidence of spinal disorders, expanding geriatric population, and increased risk of exposure are other salient factors supporting the bone growth stimulator market in North America.
Additionally, acquisitions among players in the region is projected to be another factor that will boost the market during the forecast period. For instance, in 2020, Stryker acquired Wright Medical for US$ 5.4 Billion. The initiative strengthened Stryker’s position in the market, which can propel the regional market size during the assessment period.
How is the Presence of Established Players in the Region Strengthening the Bone Growth Stimulator Market?
As per the analysis, Europe is projected to be the second largest market for bone growth stimulator market during the forecast period. The region is likely to display a CAGR of 5% from 2022 to 2032. The development of the region can be attributed to the presence of various established players in the region. Players such as Bioventus and Orthofix are expected to make a major contribution in garnering significant dividends to the region.
Various initiatives taken by players in the region are expected to augment the market size in the coming time. For instance, in June 2021, Orthofix Medical announced the U.S launch and first patient implant of the FORZA ™ Ti PLIF Spacer System. Such factors are expected to benefit the regional market in the forecast period.
How is the Large Population Base Driving the Bone Growth Stimulator Market in APAC?
The APAC market is anticipated to witness the maximum CAGR during the forecast period. The region is likely to display a CAGR of 6.5% from 2022-2032. The development of the regional market can be attributed to the large population base and the growing incidences of bones and joint problems. Further, presence of developing countries such as India, China, and Japan, among others, is another crucial factor augmenting the bone growth stimulator market.
What are Some Startups in the Bone Growth Stimulator Market?
Bioventus (U.S), ISTO Biologics (U.S), Ossatec Benelux Ltd. (Netherlands), Bone Health (U.S), Agex Therapeutics (U.S), and Theramex (U.K), are some of the emerging names in the global bone growth stimulator market.
Recent Updates from the Startups :
- In October 2021, Bioventus completed the acquisition of Misonix, a provider of minimally invasive therapeutic ultrasonic technologies. The concluded transaction creates a high-growth medical device company that will conduct business as Bioventus Inc. The acquisition is directly aligned with Bioventus’ mission of delivering innovations for active healing to patients and providers. The deal also furthers the Company’s strategy of accelerated revenue growth through acquisitions that leverage the Company’s existing infrastructure.
Competition Analysis
Key players in the global bone growth stimulator industry include Elizur Corporation, Johnson & Johnson, Arthrex Inc., DJO Global Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Medtronic Plc., and Orthofix International N.V.
Recent Updates from the Industry Include :
- In December 2020, Zimmer Biomet Holdings, Inc., announced that the company has concluded the acquisition of A&E Medical Corporation for $150 million in cash at closing and $100 million in cash payable in 2021. The deal is expected to have an immaterial impact to net earnings in 2020. Zimmer Biomet has acquired A&E Medical and its complete portfolio of sternal closure devices which includes sternal sutures, cable systems, and rigid fixation – along with a range of single-use complimentary temporary pacing wire and surgical punch products.
- In March 2020, Orthofix Medical Inc., announced its acquisition of assets associated with FITBONE ® intramedullary lengthening system for limb lengthening of the femur and tibia bones. With the initiative, Orthofix becomes the only orthopedic company that offers a comprehensive portfolio of both internal and external fixation solutions for limb reconstruction.
Key Segments Covered
-
By Product:
- Bone Growth Stimulation Devices
- Platelet-Rich Plasma Bone Growth Stimulators
- Bone Morphogenetic Protein Stimulators
-
By End User:
- Hospitals & Clinics
- Home Care
- Academic & Research Institutes and CROS
- Other End Users
-
By Application:
- Delayed Union & Nonunion Bone Fractures
- Spinal Fusion Surgeries
- Oral and Maxillofacial Surgeries
- Other Applications
-
By Region:
- North America
- Latin America
- Europe
- Japan
- APEJ
- MEA
Table of Content
- 1. Global Market Executive Summary
- 2. Global Market Overview
- 3. Global Market Analysis and Forecast By Product
- 3.1. Bone Growth Stimulation Devices
- 3.2. Platelet-Rich Plasma
- 3.3. Bone Morphogenetic Proteins
- 4. Global Market Analysis and Forecast By End User
- 4.1. Hospitals & Clinics
- 4.2. Home Care
- 4.3. Academic & Research Institutes and CROs
- 4.4. Other
- 5. Global Market Analysis and Forecast By Application
- 5.1. Delayed Union & Nonunion Bone Fractures
- 5.2. Spinal Fusion Surgeries
- 5.3. Oral and Maxillofacial Surgeries
- 5.4. Other Applications
- 6. Global Market Analysis and Forecast By Region
- 6.1. North America Market
- 6.2. Latin America Market
- 6.3. Europe Market
- 6.4. Japan Market
- 6.5. APEJ Market
- 6.6. MEA Market
- 7. North America Market Analysis and Forecast, By Country, 2017 to 2032
- 8. Latin America Market Analysis and Forecast, By Country, 2017 to 2032
- 9. Europe Market Analysis and Forecast, By Country, 2017 to 2032
- 10. Japan Market Analysis and Forecast, By Country, 2017 to 2032
- 11. APEJ Market Analysis and Forecast, By Country, 2017 to 2032
- 12. MEA Market Analysis and Forecast, By Country, 2017 to 2032
- 13. Global Market Company/Manufactures/Distributors/Suppliers Profile and Revenue Projections
- 13.1. Orthofix International N.V.
- 13.2. Medtronic plc
- 13.3. Zimmer Biomet Holdings, Inc.
- 13.4. Bioventus Inc.
- 13.5. Stryker Corporation
- 13.6. Johnson & Johnson
- 13.7. Arthrex, Inc.
- 13.8. DJO Global Inc.
- 13.9. Elizur Corporation
- 13.10. Ossatec Benelux B.V.
- 14. Disclaimer and Contact Information
List Of Table
TABLE 01: Global Market Value (US$ Mn), 2017 to 2021
TABLE 02: Global Market Value (US$ Mn), 2022 to 2032
TABLE 03: Global Market Value (US$ Mn) and Y-o-Y, 2017 to 2032
TABLE 04: Global Bone Growth Stimulation Devices Segment Value (US$ Mn), By Region 2017 to 2022
TABLE 05: Global Bone Growth Stimulation Devices Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 06: Global Bone Growth Stimulation Devices Segment Market Share, By Region 2017 to 2021
TABLE 07: Global Bone Growth Stimulation Devices Segment Market Share, By Region 2022 to 2032
TABLE 08: Global Bone Growth Stimulation Devices Segment Y-o-Y, By Region 2017 to 2032
TABLE 09: Global Platelet-Rich Plasma Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 10: Global Platelet-Rich Plasma Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 11: Global Platelet-Rich Plasma Segment Market Share, By Region 2017 to 2021
TABLE 12: Global Platelet-Rich Plasma Segment Market Share, By Region 2022 to 2032
TABLE 13: Global Platelet-Rich Plasma Segment Y-o-Y, By Region 2017 to 2032
TABLE 14: Global Bone Morphogenetic Proteins Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 15: Global Bone Morphogenetic Proteins Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 16: Global Bone Morphogenetic Proteins Segment Market Share, By Region 2017 to 2021
TABLE 17: Global Bone Morphogenetic Proteins Segment Market Share, By Region 2022 to 2032
TABLE 18: Global Bone Morphogenetic Proteins Segment Y-o-Y, By Region 2017 to 2032
TABLE 19: Global Hospitals & Clinics Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 20: Global Hospitals & Clinics Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 21: Global Hospitals & Clinics Segment Market Share, By Region 2017 to 2021
TABLE 22: Global Hospitals & Clinics Segment Market Share, By Region 2022 to 2032
TABLE 23: Global Hospitals & Clinics Segment Y-o-Y, By Region 2017 to 2032
TABLE 24: Global Home Care Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 25: Global Home Care Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 26: Global Home Care Segment Market Share, By Region 2017 to 2021
TABLE 27: Global Home Care Segment Market Share, By Region 2022 to 2032
TABLE 28: Global Home Care Segment Y-o-Y, By Region 2017 to 2032
TABLE 29: Global Academic & Research Institutes and CROS Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 30: Global Academic & Research Institutes and CROS Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 31: Global Academic & Research Institutes and CROS Segment Market Share, By Region 2017 to 2021
TABLE 32: Global Academic & Research Institutes and CROS Segment Market Share, By Region 2022 to 2032
TABLE 33: Global Academic & Research Institutes and CROS Segment Y-o-Y, By Region 2017 to 2032
TABLE 34: Global Other Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 35: Global Other Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 36: Global Other Segment Market Share, By Region 2017 to 2021
TABLE 37: Global Other Segment Market Share, By Region 2022 to 2032
TABLE 38: Global Other Segment Y-o-Y, By Region 2017 to 2032
TABLE 39: Global Delayed Union & Nonunion Bone Fractures Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 40: Global Delayed Union & Nonunion Bone Fractures Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 41: Global Delayed Union & Nonunion Bone Fractures Segment Market Share, By Region 2017 to 2021
TABLE 42: Global Delayed Union & Nonunion Bone Fractures Segment Market Share, By Region 2022 to 2032
TABLE 43: Global Delayed Union & Nonunion Bone Fractures Segment Y-o-Y, By Region 2017 to 2032
TABLE 44: Global Spinal Fusion Surgeries Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 45: Global Spinal Fusion Surgeries Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 46: Global Spinal Fusion Surgeries Segment Market Share, By Region 2017 to 2021
TABLE 47: Global Spinal Fusion Surgeries Segment Market Share, By Region 2022 to 2032
TABLE 48: Global Spinal Fusion Surgeries Segment Y-o-Y, By Region 2017 to 2032
TABLE 49: Global Oral and Maxillofacial Surgeries Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 50: Global Oral and Maxillofacial Surgeries Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 51: Global Oral and Maxillofacial Surgeries Segment Market Share, By Region 2017 to 2021
TABLE 52: Global Oral and Maxillofacial Surgeries Segment Market Share, By Region 2022 to 2032
TABLE 53: Global Oral and Maxillofacial Surgeries Segment Y-o-Y, By Region 2017 to 2032
TABLE 54: Global Other Applications Segment Value (US$ Mn), By Region 2017 to 2022
TABLE 55: Global Other Applications Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 56: Global Other Applications Segment Market Share, By Region 2017 to 2021
TABLE 57: Global Other Applications Segment Market Share, By Region 2022 to 2032
TABLE 58: Global Other Applications Segment Y-o-Y, By Region 2017 to 2032
TABLE 59: North America Market Value (US$ Mn), By Product 2017 to 2021
TABLE 60: North America Market Value (US$ Mn), By Product 2022 to 2032
TABLE 61: North America Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 62: North America Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 63: North America Market Value (US$ Mn), By Application 2017 to 2021
TABLE 64: North America Market Value (US$ Mn), By Application 2022 to 2032
TABLE 65: Latin America Market Value (US$ Mn), By Product 2017 to 2021
TABLE 66: Latin America Market Value (US$ Mn), By Product 2022 to 2032
TABLE 67: Latin America Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 68: Latin America Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 69: Latin America Market Value (US$ Mn), By Application 2017 to 2021
TABLE 70: Latin America Market Value (US$ Mn), By Application 2022 to 2032
TABLE 71: Europe Market Value (US$ Mn), By Product 2017 to 2021
TABLE 72: Europe Market Value (US$ Mn), By Product 2022 to 2032
TABLE 73: Europe Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 74: Europe Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 75: Europe Market Value (US$ Mn), By Application 2017 to 2021
TABLE 76: Europe Market Value (US$ Mn), By Application 2022 to 2032
TABLE 77: Japan Market Value (US$ Mn), By Product 2017 to 2021
TABLE 78: Japan Market Value (US$ Mn), By Product 2022 to 2032
TABLE 79: Japan Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 80: Japan Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 81: Japan Market Value (US$ Mn), By Application 2017 to 2022
TABLE 82: Japan Market Value (US$ Mn), By Application 2022 to 2032
TABLE 83: APEJ Market Value (US$ Mn), By Product 2017 to 2021
TABLE 84: APEJ Market Value (US$ Mn), By Product 2022 to 2032
TABLE 85: APEJ Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 86: APEJ Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 87: APEJ Market Value (US$ Mn), By Application 2017 to 2021
TABLE 88: APEJ Market Value (US$ Mn), By Application 2022 to 2032
TABLE 89: MEA Market Value (US$ Mn), By Product 2017 to 2021
TABLE 90: MEA Market Value (US$ Mn), By Product 2022 to 2032
TABLE 91: MEA Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 92: MEA Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 93: MEA Market Value (US$ Mn), By Application 2017 to 2021
TABLE 94: MEA Market Value (US$ Mn), By Application 2022 to 2032
TABLE 95: US Market Value (US$ Mn), By Product 2017 to 2021
TABLE 96: US Market Value (US$ Mn), By Product 2022 to 2032
TABLE 97: US Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 98: US Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 99: US Market Value (US$ Mn), By Application 2017 to 2021
TABLE 100: US Market Value (US$ Mn), By Application 2022 to 2032
TABLE 101: Canada Market Value (US$ Mn), By Product 2017 to 2021
TABLE 102: Canada Market Value (US$ Mn), By Product 2022 to 2032
TABLE 103: Canada Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 104: Canada Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 105: Canada Market Value (US$ Mn), By Application 2017 to 2021
TABLE 106: Canada Market Value (US$ Mn), By Application 2022 to 2032
TABLE 107: Argentina Market Value (US$ Mn), By Product 2017 to 2021
TABLE 108: Argentina Market Value (US$ Mn), By Product 2022 to 2032
TABLE 109: Argentina Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 110: Argentina Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 111: Argentina Market Value (US$ Mn), By Application 2017 to 2021
TABLE 112: Argentina Market Value (US$ Mn), By Application 2022 to 2032
TABLE 113: Brazil Market Value (US$ Mn), By Product 2017 to 2021
TABLE 114: Brazil Market Value (US$ Mn), By Product 2022 to 2032
TABLE 115: Brazil Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 116: Brazil Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 117: Brazil Market Value (US$ Mn), By Application 2017 to 2021
TABLE 118: Brazil Market Value (US$ Mn), By Application 2022 to 2032
TABLE 119: Mexico Market Value (US$ Mn), By Product 2017 to 2021
TABLE 120: Mexico Market Value (US$ Mn), By Product 2022 to 2032
TABLE 121: Mexico Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 122: Mexico Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 123: Mexico Market Value (US$ Mn), By Application 2017 to 2021
TABLE 124: Mexico Market Value (US$ Mn), By Application 2022 to 2032
TABLE 125: Germany Market Value (US$ Mn), By Product 2017 to 2021
TABLE 126: Germany Market Value (US$ Mn), By Product 2022 to 2032
TABLE 127: Germany Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 128: Germany Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 129: Germany Market Value (US$ Mn), By Application 2017 to 2021
TABLE 130: Germany Market Value (US$ Mn), By Application 2022 to 2032
TABLE 131: UK Market Value (US$ Mn), By Product 2017 to 2021
TABLE 132: UK Market Value (US$ Mn), By Product 2022 to 2032
TABLE 133: UK Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 134: UK Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 135: UK Market Value (US$ Mn), By Application 2017 to 2021
TABLE 136: UK Market Value (US$ Mn), By Application 2022 to 2032
TABLE 137: France Market Value (US$ Mn), By Product 2017 to 2021
TABLE 138: France Market Value (US$ Mn), By Product 2022 to 2032
TABLE 139: France Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 140: France Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 141: France Market Value (US$ Mn), By Application 2017 to 2021
TABLE 142: France Market Value (US$ Mn), By Application 2022 to 2032
TABLE 143: Spain Market Value (US$ Mn), By Product 2017 to 2021
TABLE 144: Spain Market Value (US$ Mn), By Product 2022 to 2032
TABLE 145: Spain Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 146: Spain Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 147: Spain Market Value (US$ Mn), By Application 2017 to 2021
TABLE 148: Spain Market Value (US$ Mn), By Application 2022 to 2032
TABLE 149: Italy Market Value (US$ Mn), By Product 2017 to 2021
TABLE 150: Italy Market Value (US$ Mn), By Product 2022 to 2032
TABLE 151: Italy Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 152: Italy Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 153: Italy Market Value (US$ Mn), By Application 2017 to 2021
TABLE 154: Italy Market Value (US$ Mn), By Application 2022 to 2032
TABLE 155: Nordic Market Value (US$ Mn), By Product 2017 to 2021
TABLE 156: Nordic Market Value (US$ Mn), By Product 2022 to 2032
TABLE 157: Nordic Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 158: Nordic Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 159: Nordic Market Value (US$ Mn), By Application 2017 to 2021
TABLE 160: Nordic Market Value (US$ Mn), By Application 2022 to 2032
TABLE 161: Japan Market Value (US$ Mn), By Product 2017 to 2021
TABLE 162: Japan Market Value (US$ Mn), By Product 2022 to 2032
TABLE 163: Japan Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 164: Japan Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 165: Japan Market Value (US$ Mn), By Application 2017 to 2021
TABLE 166: Japan Market Value (US$ Mn), By Application 2022 to 2032
TABLE 167: China Market Value (US$ Mn), By Product 2017 to 2021
TABLE 168: China Market Value (US$ Mn), By Product 2022 to 2032
TABLE 169: China Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 170: China Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 171: China Market Value (US$ Mn), By Application 2017 to 2021
TABLE 172: China Market Value (US$ Mn), By Application 2022 to 2032
TABLE 173: India Market Value (US$ Mn), By Product 2017 to 2021
TABLE 174: India Market Value (US$ Mn), By Product 2022 to 2032
TABLE 175: India Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 176: India Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 177: India Market Value (US$ Mn), By Application 2017 to 2021
TABLE 178: India Market Value (US$ Mn), By Application 2022 to 2032
TABLE 179: Malaysia Market Value (US$ Mn), By Product 2017 to 2021
TABLE 180: Malaysia Market Value (US$ Mn), By Product 2022 to 2032
TABLE 181: Malaysia Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 182: Malaysia Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 183: Malaysia Market Value (US$ Mn), By Application 2017 to 2021
TABLE 184: Malaysia Market Value (US$ Mn), By Application 2022 to 2032
TABLE 185: Thailand Market Value (US$ Mn), By Product 2017 to 2021
TABLE 186: Thailand Market Value (US$ Mn), By Product 2022 to 2032
TABLE 187: Thailand Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 188: Thailand Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 189: Thailand Market Value (US$ Mn), By Application 2017 to 2021
TABLE 190: Thailand Market Value (US$ Mn), By Application 2022 to 2032
TABLE 191: Singapore Market Value (US$ Mn), By Product 2017 to 2021
TABLE 192: Singapore Market Value (US$ Mn), By Product 2022 to 2032
TABLE 193: Singapore Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 194: Singapore Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 195: Singapore Market Value (US$ Mn), By Application 2017 to 2021
TABLE 196: Singapore Market Value (US$ Mn), By Application 2022 to 2032
TABLE 197: Australia Market Value (US$ Mn), By Product 2017 to 2022
TABLE 198: Australia Market Value (US$ Mn), By Product 2022 to 2032
TABLE 199: Australia Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 200: Australia Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 201: Australia Market Value (US$ Mn), By Application 2017 to 2021
TABLE 202: Australia Market Value (US$ Mn), By Application 2022 to 2032
TABLE 203: GCC Countries Market Value (US$ Mn), By Product 2017 to 2021
TABLE 204: GCC Countries Market Value (US$ Mn), By Product 2022 to 2032
TABLE 205: GCC Countries Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 206: GCC Countries Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 207: GCC Countries Market Value (US$ Mn), By Application 2017 to 2022
TABLE 208: GCC Countries Market Value (US$ Mn), By Application 2022 to 2032
TABLE 209: South Africa Market Value (US$ Mn), By Product 2017 to 2021
TABLE 210: South Africa Market Value (US$ Mn), By Product 2022 to 2032
TABLE 211: South Africa Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 212: South Africa Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 213: South Africa Market Value (US$ Mn), By Application 2017 to 2021
TABLE 214: South Africa Market Value (US$ Mn), By Application 2022 to 2032
TABLE 215: Market Value (US$ Mn), By Product 2017 to 2021
TABLE 216: Market Value (US$ Mn), By Product 2022 to 2032
TABLE 217: Market Value (US$ Mn), By End-User 2017 to 2021
TABLE 218: Market Value (US$ Mn), By End-User 2022 to 2032
TABLE 219: Market Value (US$ Mn), By Application 2017 to 2021
TABLE 220: Market Value (US$ Mn), By Application 2022 to 2032
TABLE 221: Israel Market Value (US$ Mn), By Product 2017 to 2021
TABLE 222: Israel Market Value (US$ Mn), By Product 2022 to 2032
TABLE 223: Israel Market Value (US$ Mn), By End-User 2017 to 2022
TABLE 224: Israel Market Value (US$ Mn), By End-User 2022 to 2032154
TABLE 225: Israel Market Value (US$ Mn), By Application 2017 to 2021
TABLE 226: Israel Market Value (US$ Mn), By Application 2022 to 2032
List Of Figures
FIG. 01: Global Market Value (US$ Mn), 2017 to 2021
FIG. 02: Global Market Value (US$ Mn) Forecast, 2022 to 2032
FIG. 03: Global Market Value (US$ Mn) and Y-o-Y, 2017 to 2032
FIG. 04: Global Bone Growth Stimulation Devices Segment Market Value (US$ Mn) By Region, 2017 to 2022
FIG. 05: Global Bone Growth Stimulation Devices Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 06: Global Bone Growth Stimulation Devices Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 07: Global Platelet-Rich Plasma Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 08: Global Platelet-Rich Plasma Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 09: Global Platelet-Rich Plasma Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 10: Global Bone Morphogenetic Proteins Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 11: Global Bone Morphogenetic Proteins Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 12: Global Bone Morphogenetic Proteins Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 13: Global Hospitals & Clinics Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 14: Global Hospitals & Clinics Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 15: Global Hospitals & Clinics Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 16: Global Home Care Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 17: Global Home Care Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 18: Global Home Care Segment Y-o-Y Growth Rate, By Region, 2017 to 203238
FIG. 19: Global Academic & Research Institutes and CROS Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 20: Global Academic & Research Institutes and CROS Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 21: Global Academic & Research Institutes and CROS Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 22: Global Other Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 23: Global Other Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 24: Global Other Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 25: Global Delayed Union & Nonunion Bone Fractures Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 26: Global Delayed Union & Nonunion Bone Fractures Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 27: Global Delayed Union & Nonunion Bone Fractures Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 28: Global Spinal Fusion Surgeries Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 29: Global Spinal Fusion Surgeries Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 30: Global Spinal Fusion Surgeries Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 31: Global Oral and Maxillofacial Surgeries Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 32: Global Oral and Maxillofacial Surgeries Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 33: Global Oral and Maxillofacial Surgeries Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 34: Global Other Applications Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 35: Global Other Applications Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 36: Global Other Applications Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 37: North America Market Value (US$ Mn), By Product 2017 to 2021
FIG. 38: North America Market Value (US$ Mn), By Product 2022 to 2032
FIG. 39: North America Market Value (US$ Mn), By End-User 2017 to 2021
FIG. 40: North America Market Value (US$ Mn), By End-User 2022 to 2032
FIG. 41: North America Market Value (US$ Mn), By Application 2017 to 2021
FIG. 42: North America Market Value (US$ Mn), By Application 2022 to 2032
FIG. 43: Latin America Market Value (US$ Mn), By Product 2017 to 2021
FIG. 44: Latin America Market Value (US$ Mn), By Product 2022 to 2032
FIG. 45: Latin America Market Value (US$ Mn), By End-User 2017 to 2021
FIG. 46: Latin America Market Value (US$ Mn), By End-User 2022 to 2032
FIG. 47: Latin America Market Value (US$ Mn), By Application 2017 to 2021
FIG. 48: Latin America Market Value (US$ Mn), By Application 2022 to 2032
FIG. 49: Europe Market Value (US$ Mn), By Product 2017 to 2021
FIG. 50: Europe Market Value (US$ Mn), By Product 2022 to 2032
FIG. 51: Europe Market Value (US$ Mn), By End-User 2017 to 2021
FIG. 52: Europe Market Value (US$ Mn), By End-User 2022 to 2032
FIG. 53: Europe Market Value (US$ Mn), By Application 2017 to 2021
FIG. 54: Europe Market Value (US$ Mn), By Application 2022 to 2032
FIG. 55: Japan Market Value (US$ Mn), By Product 2017 to 2021
FIG. 56: Japan Market Value (US$ Mn), By Product 2022 to 2032
FIG. 57: Japan Market Value (US$ Mn), By End-User 2017 to 2021
FIG. 58: Japan Market Value (US$ Mn), By End-User 2022 to 2032
FIG. 59: Japan Market Value (US$ Mn), By Application 2017 to 2021
FIG. 60: Japan Market Value (US$ Mn), By Application 2022 to 2032
FIG. 61: APEJ Market Value (US$ Mn), By Product 2017 to 2021
FIG. 62: APEJ Market Value (US$ Mn), By Product 2022 to 2032
FIG. 63: APEJ Market Value (US$ Mn), By End-User 2017 to 2021
FIG. 64: APEJ Market Value (US$ Mn), By End-User 2022 to 2032
FIG. 65: APEJ Market Value (US$ Mn), By Application 2017 to 2021
FIG. 66: APEJ Market Value (US$ Mn), By Application 2022 to 2032
FIG. 67: MEA Market Value (US$ Mn), By Product 2017 to 2021
FIG. 68: MEA Market Value (US$ Mn), By Product 2022 to 2032
FIG. 69: MEA Market Value (US$ Mn), By End-User 2017 to 2021
FIG. 70: MEA Market Value (US$ Mn), By End-User 2022 to 2032
FIG. 71: MEA Market Value (US$ Mn), By Application 2017 to 2021
FIG. 72: MEA Market Value (US$ Mn), By Application 2022 to 2032
- FAQs -
What is the Projected Market Value of the Global Bone Growth Stimulator Market by 2032?
The global bone growth stimulator market is expected to garner US$ 3.1 Billion by 2032.
What is the Expected CAGR of Europe in the Bone Growth Stimulator Market during the Forecast Period?
The bone growth stimulator market is expected to exhibit a CAGR of 5% during the forecast period.
At What CAGR is the Global Bone Growth Stimulator Market Expected to Expand during the Forecast Period?
The global bone growth stimulator market is anticipated to display a CAGR of 5.07% during the forecast period.
What is the Expected CAGR of the Bone Growth Stimulator Market in APAC?
The bone growth stimulator market in APAC is expected to display a CAGR of 6.5% during the forecast period.
What was the Market Value of the Global Bone Growth Stimulator Market in 2021?
The global bone growth stimulator market was valued at US$ 1.89 Billion in 2021.
Which are the Prominent Players in Global Bone Growth Stimulator Market?
Ossatec Benelux B.V., Elizur Corporation, Johnson & Johnson, and Arthrex Inc. are some of the renowned players in the global bone growth stimulator market.
Bone Growth Stimulator Market